TP53 and pancreatic neoplasm: We have previously developed autochthonous models of lung and pancreatic cancer by simultaneous Cre recombinase-mediated activation of oncogenic Kras (KrasG12D) and biallelic inactivation of p53 in cells residing in the tissues of origin11, 12, 13.